# Medpace Inc, Cincinnati, OH – FDA Inspections

Source: https://www.keypedia.com/companies/medpace-inc/e09bfcb9-1613-4cc0-8434-8913be0f770d

> Inspection records and compliance data for Medpace Inc in Cincinnati, Ohio. 11 FDA inspections on record, 1 Form 483, last inspected July 31, 2026.

---

## Details

- Name: Medpace Inc
- FEI Number: 3009316555
- Address Line 1: 5400 Medpace Way
- City: Cincinnati
- State: Ohio
- Zip Code: 45227
- Country Name: United States
- Address: 5400 Medpace Way, Cincinnati, Ohio 45227, United States
- Country: United States

## Related Documents

- FDA Inspection 1332930 - Medpace Inc - 2026-07-31 — source: FDA, date: July 31, 2026
- FDA Inspection 1263213 - Medpace Inc - 2025-02-13 — source: FDA, date: February 13, 2025
- FDA Inspection 1263213 - Medpace Inc - 2025-02-13 — classification: No Action Indicated (NAI), source: FDA, date: February 13, 2025
- [FDA Inspection 1245618 - Medpace Inc - 2024-07-11](https://www.keypedia.com/records/fda_inspections/medpace-inc/73fc50bb-105c-4d98-afdf-261bcc8d5f20) — classification: No Action Indicated (NAI), source: FDA, date: July 11, 2024
- [FDA Inspection 1232744 - Medpace Inc - 2024-03-06](https://www.keypedia.com/records/fda_inspections/medpace-inc/361b5eb5-bbfa-4117-ae30-7c27ba67b824) — classification: No Action Indicated (NAI), source: FDA, date: March 6, 2024
- FDA Inspection 1169068 - Medpace Inc - 2022-04-26 — classification: No Action Indicated (NAI), source: FDA, date: April 26, 2022
- FDA Inspection 1145127 - Medpace Inc - 2021-05-14 — classification: No Action Indicated (NAI), source: FDA, date: May 14, 2021
- [EIR - Medpace Inc - 2019-08-27](https://www.keypedia.com/records/eir/medpace-inc/e7f89f8d-2681-492e-9752-3fd7e5694142) — source: FDA, date: August 27, 2019
- FDA Inspection 1102183 - Medpace Inc - 2019-08-27 — classification: No Action Indicated (NAI), source: FDA, date: August 27, 2019
- [FDA Inspection 1050553 - Medpace Inc - 2018-04-20](https://www.keypedia.com/records/fda_inspections/medpace-inc/4de49c82-defe-41d5-b071-c87d004f46e4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 20, 2018
- [FDA Inspection 1017674 - Medpace Inc - 2017-06-16](https://www.keypedia.com/records/fda_inspections/medpace-inc/8969333d-175e-4728-9c58-9cca27393ec9) — classification: No Action Indicated (NAI), source: FDA, date: June 16, 2017

## Related Companies

- [Incyte Corporation](https://www.keypedia.com/companies/incyte-corporation/2f3187b3-71fc-4c7d-95bf-d829cc4eceec)
- [Regeneron Pharmaceuticals Inc](https://www.keypedia.com/companies/regeneron-pharmaceuticals-inc/fbb2cea0-65e4-4da9-9c5f-eea90c33a84f)
- [Sagent Pharmaceuticals](https://www.keypedia.com/companies/sagent-pharmaceuticals/9b7830c1-51dd-4d82-8287-b320eff537fd)
- [SUN PHARMACEUTICAL INDUSTRIES INC](https://www.keypedia.com/companies/sun-pharmaceutical-industries-inc/35896832-2f85-4257-b499-6aa39d1d5f3b)
- [Cody Laboratories, Inc.](https://www.keypedia.com/companies/cody-laboratories-inc/ff687af7-da97-441d-b0cd-7f20af5e87a9)
- [Ei LLC](https://www.keypedia.com/companies/ei-llc/88b53134-ac99-4eb2-b709-2a80a826ad7d)
- [Taro Pharmaceuticals U.S.A., Inc.](https://www.keypedia.com/companies/taro-pharmaceuticals-usa-inc/05da273e-af73-473f-a144-af7c4e2972c9)
- [Teva Pharmaceuticals USA, Inc](https://www.keypedia.com/companies/teva-pharmaceuticals-usa-inc/16ce5163-b7e9-4f34-adce-197945dc8b53)
- [Eisai, Inc.](https://www.keypedia.com/companies/eisai-inc/081df088-ce18-4702-a2b3-cb4e48ebe3e4)
- [Actavis Italy Spa A Socio Unico](https://www.keypedia.com/companies/actavis-italy-spa-a-socio-unico/7c4ac702-d647-4c5d-a853-472db165127e)

## Related Officers

- [company_representative](https://www.keypedia.com/people/medhi-adineh/1734a47e-5637-47fd-b262-7c27c5ab60ab)
- [recipient](https://www.keypedia.com/people/august-j-troendle/21a00158-010c-4f21-99f1-d75f63f073d4)
